Polyethylene glycol 3350 and Hyponatraemia aggravated - a phase IV clinical study of FDA data

Summary:

Hyponatraemia aggravated is reported as a side effect among people who take Polyethylene glycol 3350 (polyethylene glycol 3350), especially for people who are male, 60+ old, also take Acetaminophen, and have Dyspnea.

The phase IV clinical study analyzes which people have Hyponatraemia aggravated when taking Polyethylene glycol 3350. It is created by eHealthMe based on reports of 4,275 people who have side effects when taking Polyethylene glycol 3350 from the FDA, and is updated regularly.

What is Polyethylene glycol 3350?

Polyethylene glycol 3350 has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 4,407 Polyethylene glycol 3350 users. Check the latest studies of Polyethylene glycol 3350.

What is Hyponatraemia aggravated?

Hyponatraemia aggravated (abnormally low concentrations of sodium ions in the circulating blood) is found to be associated with 1,480 drugs and 538 conditions by eHealthMe. Check the latest studies of Hyponatraemia aggravated.

On Jul, 07, 2026

4,275 people reported to have side effects when taking Polyethylene glycol 3350.
Among them, 281 people (6.57%) have Hyponatraemia aggravated.

Could Polyethylene glycol 3350 cause Hyponatraemia aggravated?

Among these 281 people:

What is the gender of people who have Hyponatraemia aggravated when taking Polyethylene glycol 3350? *

Click here to view

What is the age of people who have Hyponatraemia aggravated when taking Polyethylene glycol 3350? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Polyethylene glycol 3350 and have Hyponatraemia aggravated?

- Check whether Hyponatraemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Polyethylene glycol 3350:

Polyethylene glycol 3350 (4,407 reports)

Hyponatraemia aggravated treatments and more:

Hyponatraemia aggravated (12 reports)

How severe was Hyponatraemia aggravated and when was it recovered:

Hyponatraemia aggravated in Polyethylene glycol 3350

Expand to all the drugs that have ingredients of polyethylene glycol 3350:

Hyponatraemia aggravated and drugs with ingredients of polyethylene glycol 3350 (1,202 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Polyethylene glycol 3350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyponatraemia aggravated:

Hyponatraemia aggravated (1,480 drugs)

Browse all the conditions that are associated with Hyponatraemia aggravated:

Hyponatraemia aggravated (538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Polyethylene glycol 3350) and Polyethylene glycol 3350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.